Objectives: We examined the advantages of tubeless percutaneous nephrolithotomy (PCNL) and totally tubeless PCNL over standard PCNL. Materials and Methods: Using a nationwide inpatient database in Japan, we gathered data on patients undergoing PCNL from July 2010 to March 2016 and extracted eligible patients who were candidates for tubeless PCNL. Eligible patients were divided into 4 groups: tubeless, totally tubeless, standard, and standard PCNL with ureteral stent (US). Multivariable analyses compared postoperative hospital stay, duration of analgesic use, urinary tract infection (UTI), and blood transfusion among the 4 groups. Results: Analyses were conducted on patients in the standard (n = 954), tubeless (n = 98), totally tubeless (n = 146), and standard PCNL with US (n = 389) groups. Postoperative hospital stay was significantly shorter in the tubeless group than in the standard group (1.6 days [–2.9 to 0.4]). With reference to the standard PCNL group, there was no significant difference in the number of days of analgesic use or the proportions of postoperative UTIs or blood transfusion among the groups. Postoperative UTIs developed significantly more often in women than in men regardless of the PCNL method. Conclusions: Our multivariable analyses showed that tubeless PCNL was associated with shorter postoperative hospital stays, but totally tubeless PCNL was not.

1.
Bellman
GC
,
Davidoff
R
,
Candela
J
,
Gerspach
J
,
Kurtz
S
,
Stout
L
.
Tubeless percutaneous renal surgery
.
J Urol
.
1997
May
;
157
(
5
):
1578
82
.
[PubMed]
0022-5347
2.
Karami
H
,
Gholamrezaie
HR
.
Totally tubeless percutaneous nephrolithotomy in selected patients
.
J Endourol
.
2004
Jun
;
18
(
5
):
475
6
.
[PubMed]
0892-7790
3.
Choi
M
,
Brusky
J
,
Weaver
J
,
Amantia
M
,
Bellman
GC
.
Randomized trial comparing modified tubeless percutaneous nephrolithotomy with tailed stent with percutaneous nephrostomy with small-bore tube
.
J Endourol
.
2006
Oct
;
20
(
10
):
766
70
.
[PubMed]
0892-7790
4.
Agrawal
MS
,
Agrawal
M
,
Gupta
A
,
Bansal
S
,
Yadav
A
,
Goyal
J
.
A randomized comparison of tubeless and standard percutaneous nephrolithotomy
.
J Endourol
.
2008
Mar
;
22
(
3
):
439
42
.
[PubMed]
0892-7790
5.
Shah
HN
,
Mahajan
AP
,
Hegde
SS
,
Bansal
M
.
Tubeless percutaneous nephrolithotomy in patients with previous ipsilateral open renal surgery: a feasibility study with review of literature
.
J Endourol
.
2008
Jan
;
22
(
1
):
19
24
.
[PubMed]
0892-7790
6.
Giusti
G
,
Piccinelli
A
,
Maugeri
O
,
Benetti
A
,
Taverna
G
,
Graziotti
P
.
Percutaneous nephrolithotomy: tubeless or not tubeless?
Urol Res
.
2009
Jun
;
37
(
3
):
153
8
.
[PubMed]
0300-5623
7.
Istanbulluoglu
MO
,
Ozturk
B
,
Gonen
M
,
Cicek
T
,
Ozkardes
H
.
Effectiveness of totally tubeless percutaneous nephrolithotomy in selected patients: a prospective randomized study
.
Int Urol Nephrol
.
2009
;
41
(
3
):
541
5
.
[PubMed]
0301-1623
8.
Aghamir
SM
,
Modaresi
SS
,
Aloosh
M
,
Tajik
A
.
Totally tubeless percutaneous nephrolithotomy for upper pole renal stone using subcostal access
.
J Endourol
.
2011
Apr
;
25
(
4
):
583
6
.
[PubMed]
0892-7790
9.
Chang
CH
,
Wang
CJ
,
Huang
SW
.
Totally tubeless percutaneous nephrolithotomy: a prospective randomized controlled study
.
Urol Res
.
2011
Dec
;
39
(
6
):
459
65
.
[PubMed]
0300-5623
10.
Marchant
F
,
Recabal
P
,
Fernández
MI
,
Osorio
F
,
Benavides
J
.
Postoperative morbidity of tubeless versus conventional percutaneous nephrolithotomy: a prospective comparative study
.
Urol Res
.
2011
Dec
;
39
(
6
):
477
81
.
[PubMed]
0300-5623
11.
Cormio
L
,
Perrone
A
,
Di Fino
G
,
Ruocco
N
,
De Siati
M
,
de la Rosette
J
, et al.
TachoSil(®) sealed tubeless percutaneous nephrolithotomy to reduce urine leakage and bleeding: outcome of a randomized controlled study
.
J Urol
.
2012
Jul
;
188
(
1
):
145
50
.
[PubMed]
0022-5347
12.
Crook
TJ
,
Lockyer
CR
,
Keoghane
SR
,
Walmsley
BH
.
A randomized controlled trial of nephrostomy placement versus tubeless percutaneous nephrolithotomy
.
J Urol
.
2008
Aug
;
180
(
2
):
612
4
.
[PubMed]
0022-5347
13.
Istanbulluoglu
MO
,
Cicek
T
,
Ozturk
B
,
Gonen
M
,
Ozkardes
H
.
Percutaneous nephrolithotomy: nephrostomy or tubeless or totally tubeless?
Urology
.
2010
May
;
75
(
5
):
1043
6
.
[PubMed]
0090-4295
14.
OECD Health Statistics
. 2017. OECD
2017
. Available at: http://www.oecd.org/els/health-systems/health-data.htm. Accessed April 18, 2018.
15.
Cormio
L
,
Gonzalez
GI
,
Tolley
D
,
Sofer
M
,
Muslumanoglu
A
,
Klingler
HC
, et al.
Exit strategies following percutaneous nephrolithotomy (PCNL): a comparison of surgical outcomes in the Clinical Research Office of the Endourological Society (CROES) PCNL Global Study
.
World J Urol
.
2013
Oct
;
31
(
5
):
1239
44
.
[PubMed]
0724-4983
16.
Leow
JJ
,
Meyer
CP
,
Wang
Y
,
Chang
SL
,
Chung
BI
,
Trinh
QD
, et al.
Contemporary trends in utilization and perioperative outcomes of percutaneous nephrolithotomy in the United States from 2003 to 2014
.
J Endourol
.
2017
Aug
;
31
(
8
):
742
50
.
[PubMed]
0892-7790
17.
Armitage
JN
,
Irving
SO
,
Burgess
NA
;
British Association of Urological Surgeons Section of Endourology
.
Percutaneous nephrolithotomy in the United kingdom: results of a prospective data registry
.
Eur Urol
.
2012
Jun
;
61
(
6
):
1188
93
.
[PubMed]
0302-2838
18.
Kamphuis
GM
,
Baard
J
,
Westendarp
M
,
de la Rosette
JJ
.
Lessons learned from the CROES percutaneous nephrolithotomy global study
.
World J Urol
.
2015
Feb
;
33
(
2
):
223
33
.
[PubMed]
0724-4983
19.
Rizvi
SA
,
Hussain
M
,
Askari
SH
,
Hashmi
A
,
Lal
M
,
Zafar
MN
.
Surgical outcomes of percutaneous nephrolithotomy in 3402 patients and results of stone analysis in 1559 patients
.
BJU Int
.
2017
Nov
;
120
(
5
):
702
9
.
[PubMed]
1464-4096
20.
Michel
MS
,
Trojan
L
,
Rassweiler
JJ
.
Complications in percutaneous nephrolithotomy
.
Eur Urol
.
2007
Apr
;
51
(
4
):
899
906
.
[PubMed]
0302-2838
21.
Mariappan
P
,
Smith
G
,
Moussa
SA
,
Tolley
DA
.
One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study
.
BJU Int
.
2006
Nov
;
98
(
5
):
1075
9
.
[PubMed]
1464-4096
22.
Bag
S
,
Kumar
S
,
Taneja
N
,
Sharma
V
,
Mandal
AK
,
Singh
SK
.
One week of nitrofurantoin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study
.
Urology
.
2011
Jan
;
77
(
1
):
45
9
.
[PubMed]
0090-4295
23.
Deshmukh
S
,
Sternberg
K
,
Hernandez
N
,
Eisner
BH
.
Compliance with American Urological Association guidelines for post-percutaneous nephrolithotomy antibiotics does not appear to increase rates of infection
.
J Urol
.
2015
Oct
;
194
(
4
):
992
6
.
[PubMed]
0022-5347
24.
Sammon
JD
,
Ghani
KR
,
Karakiewicz
PI
,
Bhojani
N
,
Ravi
P
,
Sun
M
, et al.
Temporal trends, practice patterns, and treatment outcomes for infected upper urinary tract stones in the United States
.
Eur Urol
.
2013
Jul
;
64
(
1
):
85
92
.
[PubMed]
0302-2838
25.
Armitage
JN
,
Withington
J
,
van der Meulen
J
,
Cromwell
DA
,
Glass
J
,
Finch
WG
, et al.
Percutaneous nephrolithotomy in England: practice and outcomes described in the Hospital Episode Statistics database
.
BJU Int
.
2014
May
;
113
(
5
):
777
82
.
[PubMed]
1464-4096
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.